Thea Norman - Concepedia

Author

Thea Norman

Also Known As

Caloian, Cristian, Iyappan, Anandhi, Ken Chen, Knapp, Bettina, Michael R Kellen, Norman, Thea, T Norman, T. C. NORMAN, Thea C Norman, Thea C. Norman

Publications

5.5K

Citations

H-Index

135

Concepts

All Affiliations

Sage Bionetworks University of California, Berkeley Stanford University University of California, San Francisco Gates Foundation

About

Thea Norman is an author at Sage Bionetworks specializing in medicine, engineering, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	1.7K
2	Engineering	9	10	782
3	Natural Sciences	6	6	707
4	Education	3	3	97
5	Health Sciences	1	1	10

Thea Norman

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
Exploiting Chemical Libraries, Structure, and Genomics in the Search for Kinase Inhibitors Nathanael S. Gray, Lisa Wodicka, A.M.W.H. Thunnissen, Science	1998	806
Evaluation of Combined Artificial Intelligence and Radiologist Assessment to Interpret Screening Mammograms Thomas Schaffter, Diana S.M. Buist, Christoph I. Lee, JAMA Network Open	2020	400
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen Michael P. Menden, Dennis Wang, Mike J. Mason, Nature Communications	2019	350
Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors Young‐Tae Chang, Nathanael S. Gray, Gustavo R. Rosania, Chemistry & Biology Combinatorial ChemistryCdk InhibitorsBiochemistryMedicinePharmacological Agent	1999	267
Integrating transcriptional and metabolite profiles to direct the engineering of lovastatin-producing fungal strains Manor Askenazi, Edward M. Driggers, Douglas A. Holtzman, Nature Biotechnology Lovastatin-producing Fungal StrainsEngineeringBiochemistryBiotechnologySynthetic Biology	2003	244
Inferring causal molecular networks: empirical assessment through a community-based effort Steven M. Hill, Laura M. Heiser, Thomas Cokelaer, Nature Methods	2016	239
Optimized clinical performance of growth hormone with an expanded genetic code Ho Cho, T. Sheidy Daniel, Ying J. Buechler, Proceedings of the National Academy of Sciences Human GrowthGeneticsGlycobiologyHomogeneous Hgh VariantsOptimized Clinical Performance	2011	197
Genetic Selection of Peptide Inhibitors of Biological Pathways Thea Norman, Dana L. Smith, Peter K. Sorger, Science Genetic SelectionsSystems BiologyEngineeringDrug TargetSpindle Checkpoint	1999	188
FGF21 Analogs of Sustained Action Enabled by Orthogonal Biosynthesis Demonstrate Enhanced Antidiabetic Pharmacology in Rodents James Mu, Jason Pinkstaff, Zhihua Li, Diabetes Fgf21 AnalogsGlycobiologyCellular PharmacologyInsulin SignalingTranslational Pharmacology	2011	158
CVT-313, a Specific and Potent Inhibitor of CDK2 That Prevents Neointimal Proliferation Eric E. Brooks, Nathanael S. Gray, Alison Joly, Journal of Biological Chemistry	1997	141

Page 1